中國醫療(08225.HK)啟動兩項臨床研究
中國醫療(08225.HK)公布,已建立中國醫療精神心理喜心大醫生、喜恩抗癡呆卒中大醫生MyD數位醫療專科研究型門診,並啟動相關臨床研究。另外旗下精神心理喜心臨床研究中心與內地頂尖醫療機構,亦啟動男性健康專科能力建設專案。
集團表示,本次啟動兩項個試驗,計劃在兩年內完成一萬宗病例研究,認為深耕該兩個病種的臨床研究,對企業臨床研究中心會有長期正面影響,料專科能力建設專案對企業長期收入產生重要影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.